![]() Financial Daily from THE HINDU group of publications Sunday, Apr 20, 2003 |
|
|
|
|
|
Marketing
-
New Products & Services Aurobindo joint venture launches new product Our Bureau
HYDERABAD, April 19 PHARMACEUTICAL major Aurobindo Pharma Ltd (APL), has announced here that its joint venture with Citadel - Citadel Aurobindo Bitoech Ltd - has launched a new product Aztreonam, a monobactam betalactum antibiotic, for the first time in the Indian pharmaceutical market. Branded as `Treonam', the drug is claimed to be highly useful for the treatment of infections due to gram negative aerobes including pseudomonas aeruginosa, a highly difficult to treat pathogen. According to Aurobindo Pharma, the drug is a useful antibiotic in hospital and ICU setting for infections such as pyelonephritis, septicaemia, pneumonia, post-operative wounds and burns, intra-abdominal infections, gynaecological infections and surgery.
Article E-Mail :: Comment :: Syndication
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |
Copyright © 2003, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|